OpenURL Connection Search

Select item for more details and to access through your institution.

CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.
Published in:
Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 3, p. 559, doi. 10.1007/s00432-017-2565-5
By:
- Schmalenberg, Harald;
- Al-Batran, Salah-Eddin;
- Pauligk, Claudia;
- Zander, Thomas;
- Reichart, Alexander;
- Lindig, Udo;
- Kleiß, Mathias;
- Müller, Lothar;
- Bolling, Claus;
- Seufferlein, Thomas;
- Reichardt, Peter;
- Kullmann, Frank;
- Eschenburg, Henning;
- Schmittel, Alexander;
- Egger, Matthias;
- Block, Andreas;
- Goetze, Thorsten Oliver
Publication type:
Article
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
Published in:
2017
By:
- Al-Batran, Salah-Eddin;
- Goetze, Thorsten O.;
- Mueller, Daniel W.;
- Vogel, Arndt;
- Winkler, Michael;
- Lorenzen, Sylvie;
- Novotny, Alexander;
- Pauligk, Claudia;
- Homann, Nils;
- Jungbluth, Thomas;
- Reissfelder, Christoph;
- Caca, Karel;
- Retter, Steffen;
- Horndasch, Eva;
- Gumpp, Julia;
- Bolling, Claus;
- Fuchs, Karl-Hermann;
- Wolfgang Blau;
- Padberg, Winfried;
- Pohl, Michael
Publication type:
journal article
Exercise improves functional capacity and lean body mass in patients with gastrointestinal cancer during chemotherapy: a single-blind RCT.
Published in:
2019
By:
- Stuecher, Katrin;
- Vogt, Lutz;
- Niederer, Daniel;
- Banzer, Winfried;
- Schmidt, Katharina;
- Bolling, Claus;
- Dignaß, Axel
Publication type:
journal article
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 4073, doi. 10.1245/s10434-024-15011-7
By:
- Goetze, Thorsten O.;
- Reichart, Alexander;
- Bankstahl, Ulli S.;
- Pauligk, Claudia;
- Loose, Maria;
- Kraus, Thomas W.;
- Elshafei, Moustafa;
- Bechstein, Wolf O.;
- Trojan, Jörg;
- Behrend, Matthias;
- Homann, Nils;
- Venerito, Marino;
- Bohle, Wolfram;
- Varvenne, Michael;
- Bolling, Claus;
- Behringer, Dirk M.;
- Kratz-Albers, Karsten;
- Siegler, Gabriele M.;
- Hozaeel, Wael;
- Al-Batran, Salah-Eddin
Publication type:
Article
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 11, p. 945, doi. 10.1093/ecco-jcc/jjv141
By:
- Annese, Vito;
- Beaugerie, Laurent;
- Egan, Laurence;
- Biancone, Livia;
- Bolling, Claus;
- Brandts, Christian;
- Dierickx, Daan;
- Dummer, Reinhard;
- Fiorino, Gionata;
- Gornet, Jean Marc;
- Higgins, Peter;
- Katsanos, Konstantinos H.;
- Nissen, Loes;
- Pellino, Gianluca;
- Rogler, Gerhard;
- Scaldaferri, Franco;
- Szymanska, Edyta;
- Eliakim, Rami
Publication type:
Article

Found: 5

CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.

Exercise improves functional capacity and lean body mass in patients with gastrointestinal cancer during chemotherapy: a single-blind RCT.

Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial.

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.